DiaMedica Therapeutics (DMAC) Interest Coverage Ratio (2018 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Interest Coverage Ratio came in at 455.74 in Q1 2026, up 94.4% year-on-year from 234.43 in Q1 2025, and down 130883.57% quarter-over-quarter from 0.35 in Q4 2025.
DiaMedica Therapeutics (DMAC) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Interest Coverage Ratio history runs 9 years deep, the most recent figure standing at 455.74 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 94.4% year-over-year to 455.74 in Q1 2026; TTM through Mar 2026 was 854.3, a 41.25% increase from a year earlier, with the FY2025 full-year figure at 0.81, down 3.91% from the prior year.
- Interest Coverage Ratio eased to 455.74 in Q1 2026 per DMAC's latest filing, from 0.35 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.35 in Q4 2025 and bottomed at 8144.0 in Q1 2025.
- The 5-year median for Interest Coverage Ratio is 6.23 (2023), against an average of 784.16.
- Across the five-year window, Interest Coverage Ratio slumped 545981.9% in 2022 and soared 98.65% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 4.78 in 2022, then plunged by 47.19% to 7.03 in 2023, then jumped by 88.31% to 0.82 in 2024, then soared by 57.67% to 0.35 in 2025, then plunged by 130883.57% to 455.74 in 2026.
- Per Business Quant, the three latest DMAC Interest Coverage Ratio figures stand at 455.74 (Q1 2026), 0.35 (Q4 2025), and 0.43 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | DiaMedica Therapeutics | 364.72 Mn | 364.72 Mn | - | -455.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -455.74 |
| Dec 31, 2025 | -0.35 |
| Sep 30, 2025 | -0.43 |
| Jun 30, 2025 | -2.13 |
| Mar 31, 2025 | -8,144.00 |
| Dec 31, 2024 | -0.82 |
| Sep 30, 2024 | -1.41 |
| Jun 30, 2024 | -5.44 |
| Mar 31, 2024 | -302.16 |
| Dec 31, 2023 | -7.03 |
| Sep 30, 2023 | -11.16 |
| Jun 30, 2023 | -1.27 |
| Mar 31, 2023 | -47.59 |
| Dec 31, 2022 | -4.78 |
| Sep 30, 2022 | -26.29 |
| Mar 31, 2022 | -3,536.00 |
| Dec 31, 2021 | -190.94 |
| Sep 30, 2021 | -13.56 |
| Jun 30, 2021 | -42.59 |
| Mar 31, 2021 | -0.65 |